Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Eur J Nutr ; 62(8): 3339-3347, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37594507

ABSTRACT

PURPOSE: Maintaining an appropriate hydration level by ingesting fluid in a hot environment is a measure to prevent heat-related illness. Caffeine-containing beverages, including green tea (GT), have been avoided as inappropriate rehydration beverages to prevent heat-related illness because caffeine has been assumed to exert diuretic/natriuretic action. However, the influence of caffeine intake on urine output in dehydrated individuals is not well documented. The aim of the present study was to examine the effect of fluid replacement with GT on body fluid balance and renal water and electrolyte handling in mildly dehydrated individuals. METHODS: Subjects were dehydrated by performing three bouts of stepping exercise for 20 min separated by 10 min of rest. They were asked to ingest an amount of water (H2O), GT, or caffeinated H2O (20 mg/100 ml; Caf-H2O) that was equal to the volume of fluid loss during the dehydration protocol; fluid balance was measured for 2 h after fluid ingestion. RESULTS: The dehydration protocol induced hypohydration by ~ 10 g/kg body weight (~ 1% of body weight). Fluid balance 2 h after fluid ingestion was significantly less negative in all trials, and the fluid retention ratio was 52.2 ± 4.2% with H2O, 51.0 ± 5.0% with GT, and 47.9 ± 6.2% with Caf-H2O; those values did not differ among the trials. After rehydration, urine output, urine osmolality, and urinary excretions of osmotically active substances, sodium, potassium and chloride were not different among the trials. CONCLUSION: The data indicate that ingestion of GT or an equivalent caffeine amount does not worsen the hydration level 2 h after ingestion and can be effective in reducing the negative fluid balance for acute recovery from mild hypohydration. TRIAL REGISTRATION: ISRCTN53057185; retrospectively registered.


Subject(s)
Dehydration , Tea , Humans , Dehydration/prevention & control , Caffeine , Cross-Over Studies , Water-Electrolyte Balance , Water , Body Weight
2.
Nutrients ; 14(6)2022 Mar 15.
Article in English | MEDLINE | ID: mdl-35334892

ABSTRACT

Sex steroids modify feeding behavior and body weight regulation, and androgen reportedly augments food intake and body weight gain. To elucidate the role of endogenous androgens in the feeding regulation induced by reduced glucose availability, we examined the effect of gonadectomy (orchiectomy) on food intake and orexin A neuron's activity in the lateral hypothalamic/perifornical area (LH/PFA) in response to reduced glucose availability (glucoprivation) induced by 2-deoxy-d-glucose (2DG) administration in male rats. Rats (7W) were bilaterally orchiectomized (ORX group) or sham operated (Sham group). Seventeen days after the surgery, food intake response to 2DG (400 mg/kg, i.v.) was measured for 4 h after the infusion. The same experiment was performed for the immunohistochemical examination of c-Fos-expressing orexin A neurons in the LH/PFA and c-Fos expression in the arcuate nucleus (Arc). Food intake induced by glucoprivation was greater in the ORX group than the Sham group, and the glucoprivation-induced food intake was inversely correlated with plasma testosterone concentration. Glucoprivation stimulated c-Fos expression of the orexin A neurons at the LH/PFA and c-Fos expression in the dorsomedial Arc. The number and percentage of c-Fos-expressing orexin A neurons in the LH/PFA and c-Fos expression in the dorsomedial Arc were significantly higher in the ORX group than the Sham group. This indicates that endogenous androgen, possibly testosterone, diminishes the food intake induced by reduced glucose availability, possibly via the attenuated activity of orexin A neuron in the LH/PFA and neurons in the dorsomedial Arc.


Subject(s)
Androgens , Neuropeptides , Androgens/metabolism , Androgens/pharmacology , Animals , Eating/physiology , Glucose/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Male , Neurons/metabolism , Neuropeptides/metabolism , Orexins/metabolism , Rats
3.
Chemosphere ; 210: 139-146, 2018 Nov.
Article in English | MEDLINE | ID: mdl-29986219

ABSTRACT

Diclofenac is widely distributed in freshwater environments. To support a robust aquatic risk assessment, medaka (Oryzias latipes) were exposed to diclofenac at sublethal concentrations of 0.608, 2.15, 7.29, 26.5, and 94.8 µg/L (as mean measured concentrations) from fertilized eggs to 90-day posthatch. Except for the induction of mandibular defects, no deleterious effects were observed on hatching success and time to hatching at the embryonic stage, or on posthatch mortality, growth in hatched larvae and juveniles, and no abnormal behavior was observed. After 40-day posthatch, mandibular defects in the fish were observed at a concentration of 7.29 µg/L and above. Cumulatively, a morphological examination showed that 4% of the fish in the 7.29 µg/L treatment, 20% in the 26.5 µg/L treatment, and 38% in the 94.8 µg/L treatment exhibited mandibular defects, and the sex ratio of fish with mandibular defects was skewed toward males. These results suggest that diclofenac affects bone remodeling in the lower jaw of medaka after puberty in a sex-dependent manner. The lowest observed-effect concentration and no observed-effect concentration of diclofenac for mandibular dysmorphism through the partial life cycle exposure of the medaka were 26.5 and 7.29 µg/L, respectively.


Subject(s)
Diclofenac/pharmacology , Mandible/abnormalities , Oryzias/growth & development , Water Pollutants, Chemical/pharmacology , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Female , Larva/growth & development , Male , Mandible/drug effects , Sex Factors , Sex Ratio
4.
Environ Toxicol Chem ; 36(12): 3277-3283, 2017 12.
Article in English | MEDLINE | ID: mdl-28636229

ABSTRACT

Mating pairs of medaka (Oryzias latipes) were exposed to diclofenac at measured concentrations of 0 (control), 7.1, 37, and 78 µg/L for 14 d under static-renewal conditions. Effects on reproductive success, as well as morphological abnormalities, of the fish were assessed. During the exposure period, both fecundity and fertility were significantly decreased in the 37- and 78-µg/L treatment groups, and swollen abdomens in females were observed in all exposure groups. Notably, a defect of the lower jaw was also observed in 4 male fish: 2 at 37 µg/L and 2 at 78 µg/L of diclofenac. Subsequently, we investigated whether the reproductive and morphological abnormalities induced by diclofenac would be permanent or reversible once the medaka were returned to clean water. The reproductive ability of paired medaka was gradually restored to fish that were cultured in clean water for 14 d. After this period in clean water, we also observed a noticeable decrease in swollen abdomens in females; however, mandibular defects in the males remained, even after the 14-d recovery period. Radiographic and histochemical examinations revealed that diclofenac might affect bone remodeling in the lower jaw of male medaka because of a disruption in osteoclast function. These results suggest that reproductive impairments in pairs of medaka exposed to diclofenac may be reversible but that skeletal deformities (i.e., mandibular defect) in males may be persistent. Environ Toxicol Chem 2017;36:3277-3283. © 2017 SETAC.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/toxicity , Diclofenac/toxicity , Oryzias/physiology , Water Pollutants, Chemical/toxicity , Animals , Bone Remodeling/drug effects , Female , Fertility/drug effects , Male , Oryzias/abnormalities , Reproduction/drug effects
5.
Environ Toxicol ; 31(12): 1710-1719, 2016 Dec.
Article in English | MEDLINE | ID: mdl-26183440

ABSTRACT

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used therapeutic agents; however, their pharmacological actions raise concerns about potential risks to the reproductive health of aquatic vertebrates. In the present study, a medaka ovulation assay was applied as an in vitro model to evaluate NSAID-induced antiovulatory activity. We first tested five NSAIDs, including diclofenac sodium (DCF), ketoprofen (KP), salicylic acid (SA), mefenamic acid (MA), and acetylsalicylic acid (ASA) for their antiovulatory activities toward the follicles isolated from the ovaries of spawning females. Of all the chemicals tested, DCF had the highest antiovulatory activity, with the concentration that caused 50% inhibition (IC50) (101 µM). MA was the second most potent inhibitor following DCF, but KP, SA, or ASA had little inhibitory effect on the ovulation of the follicles. The in vitro antiovulatory activity of five NSAIDs showed good correlation with data published on the inhibitory activity on human COX-2. Second, we selected DCF and SA as the most and least potent NSAIDs, respectively, and examined the effects on reproduction of intact fish in order to evaluate whether the ovulation assay was a reasonable predictor of potential reproductive effects in fish. Females exposed to DCF showed a concentration-dependent decrease in the number of spawned eggs and an increment in the gonadosomatic index (GSI), possibly due to an anovulation in the females. In contrast, neither fecundity nor the GSI of females decreased at up to 20 mg/L of SA, at which acute lethality to medaka was induced. In conclusion, the medaka ovulation assay reflected the potency of NSAID-induced antiovulatory activity and may thus serve as an in vitro model for the prediction of NSAID-induced reproductive toxicity. © 2015 Wiley Periodicals, Inc. Environ Toxicol 31: 1710-1719, 2016.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/toxicity , Oryzias/physiology , Ovary/drug effects , Reproduction/drug effects , Water Pollutants, Chemical/toxicity , Animals , Aspirin/toxicity , Diclofenac/toxicity , Female , Humans , Ketoprofen/toxicity , Mefenamic Acid/toxicity , Ovary/cytology , Ovulation/drug effects , Ovum/drug effects , Ovum/physiology , Salicylic Acid/toxicity
6.
Aquat Toxicol ; 105(3-4): 708-16, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21996257

ABSTRACT

A global effort has been made to establish screening and testing methods that can identify the effects of endocrine-disrupting chemicals (EDCs) on invertebrates. The purpose of our study was to develop an in vitro receptor binding assay for ecdysone receptor (EcR) in mysid shrimp (Americamysis bahia). We cloned mysid shrimp EcR cDNA (2888 nucleotides) and ultraspiracle (USP) cDNA (2116 nucleotides), and determined that they encode predicted proteins of length 570 and 410 amino acids, respectively. The deduced amino acid sequences of these proteins shared 36-71% homology for EcR and 44-65% for USP with those of other arthropods. Phylogenetic analysis revealed that mysid shrimp EcR was classified into an independent cluster together with the EcRs of another mysid species, Neomysis integer and the cluster diverged early from those of the other taxonomic orders of crustaceans. We then expressed the ligand-binding domains (DEF regions) of mysid shrimp EcR (abEcRdef) and USP (abUSPdef) as glutathione S-transferase (GST)-fusion peptides in Escherichia coli. After purifying the fusion peptides by affinity chromatography and removing the GST labels, we subjected the peptides to a ligand-receptor binding assay. [(3)H]-ponasterone A did not bind to abEcRdef or abUSPdef peptides alone but bound strongly to the abEcRdef/abUSPdef mixture with dissociation constant (K(d))=2.14 nM. Competitive binding assays showed that the IC(50) values for ponasterone A, muristerone A, 20-hydroxyecdysone, and α-ecdysone were 1.2, 1.9, 35, and 1200 nM, respectively. In contrast, the IC(50) values for two dibenzoylhydrazine ligands (tebufenozide and chromafenozide) were >1.0 × 10(5)nM. The intra- and inter-assay coefficient of variation values for the IC(50) values of 20-hydroxyecdysone were 14.7% (n=5) and 16.1% (n=8), respectively. Our results indicate that the binding assay with a mixture of abEcRdef and abUSPdef can be used to screen compounds with a broad range of binding affinities for crustacean EcRs.


Subject(s)
Binding, Competitive , Decapoda/metabolism , Endocrine Disruptors/toxicity , Receptors, Steroid/metabolism , Toxicity Tests/methods , Water Pollutants, Chemical/toxicity , Animals , Arthropod Proteins/genetics , Arthropod Proteins/metabolism , Base Sequence , DNA, Complementary/analysis , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Decapoda/genetics , In Vitro Techniques , Inhibitory Concentration 50 , Molecular Sequence Data , Phylogeny , Protein Binding , Receptors, Steroid/genetics , Sequence Analysis, DNA , Transcription Factors/genetics , Transcription Factors/metabolism
7.
Arch Environ Contam Toxicol ; 58(3): 684-93, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19771461

ABSTRACT

The concentrations of organotin compounds in the aquatic environment of Maizuru Bay and their spatial distribution are discussed. The concentrations of tributyltin (TBT) compounds in water samples ranged from 0.001 to 0.002 microg l(-1), and monobutyltin compounds were the dominant species among the butyltin compounds. TBT concentrations in Maizuru Bay are low compared with other coastal waters of Japan. Drastic differences in TBT concentrations were not observed among the Maizuru Bay sites. Phenyltin compounds were not detected in the water samples. Concentrations of TBT and triphenyltin (TPT) in sediment from Maizuru Bay ranged, respectively, from 0.9 to 11 microg kg(-1), from 0.2 to 17 microg kg(-1) dry weight (dw). TBT concentrations in Maizuru Bay were lower than those in other coastal areas of Japan. TPT concentrations were greater than TBT concentrations in the fishing port. The concentrations of TBT and TPT in blue mussels (M. galloprovincialis) from Maizuru Bay were in the range of 2.4 to 9.3 microg kg(-1) and 0.2-13 microg kg(-1) wet weight (ww), respectively. A tolerable average residue level (TARL) was estimated at 74.8 microg kg(-1) from a tolerable daily intake (TDI) of 0.25 bis(tributyltin)oxide microg kg(-1) body weight day(-1). TBT concentrations detected in blue mussel samples were lower than the TARL values. The acceptable concentration of TPT, which were calculated using acceptable daily intake instead of TDI, was 127 microg kg(-1). Concentrations of TPT in blue mussel samples were also lower than the TARL. TBT compounds in blue mussel samples were at similar levels among the various sampling sites, indicating that TBT is not currently being used in ship hull paints; the ratios of degradation products of TBT and TPT were greater than those of the parent compounds. Concentrations of alternative biocides in water samples were also investigated in the bay. Although Sea-Nine 211, M1, and Pyrithiones were not detected, Diuron and Irgarol 1051 were detected at 0.010-0.257 and at 0.002-0.018 microg l(-1), respectively. Concentrations of Diuron were great in the shipping route and near the shipyard, whereas the concentration of Irgarol 1051 was great at the fishing port. Concentrations of Diuron and Irgarol 1051 in sediment from Maizuru Bay ranged, respectively, from <0.08 to 12, from <0.08 to 9.8 microg kg(-1) dw, respectively. Despite being a semi-enclosed bay, we found that sediment in Maizuru Bay is not contaminated by alternative biocides to the degree found in other coastal areas. Copper concentrations of sediment were at ordinary levels, and those of blue mussels were slightly lower than those reported previously in other coastal areas of Japan. In both the sediment and blue mussels, there was no correlation between the presence of copper and antifouling biocides.


Subject(s)
Disinfectants/analysis , Environmental Monitoring , Organotin Compounds/analysis , Water Pollutants, Chemical/analysis , Animals , Copper/analysis , Diuron/analysis , Geologic Sediments/analysis , Mytilus edulis/chemistry , Organotin Compounds/metabolism , Trialkyltin Compounds/analysis
8.
Cancer Res ; 67(1): 194-201, 2007 Jan 01.
Article in English | MEDLINE | ID: mdl-17210699

ABSTRACT

hTERT, which encodes the catalytic subunit of telomerase and is expressed in most immortalized and cancer cells, has been reported to have increased DNA methylation in its promoter region in many cancers. This pattern is inconsistent with observations that DNA methylation of promoter CpG islands is typically associated with gene silencing. Here, we provide a comprehensive analysis of promoter DNA methylation, chromatin patterns, and expression of hTERT in cancer and immortalized cells. Methylation-specific PCR and bisulfite sequencing of the hTERT promoter in breast, lung, and colon cancer cells show that all cancer cell lines retain alleles with little or no methylation around the transcription start site despite being densely methylated in a region 600 bp upstream of the transcription start site. By real-time reverse transcription-PCR, all cancer cell lines express hTERT. Chromatin immunoprecipitation (ChIP) analysis reveals that both active (acetyl-H3K9 and dimethyl-H3K4) and inactive (trimethyl-H3K9 and trimethyl-H3K27) chromatin marks are present across the hTERT promoter. However, using a novel approach combining methylation analysis of ChIP DNA, we show that active chromatin marks are associated with unmethylated DNA, whereas inactive marks of chromatin are associated with methylated DNA in the region around the transcription start site. These results show that DNA methylation patterns of the hTERT promoter (-150 to +150 around the transcription start) are consistent with the usual dynamics of gene expression in that the absence of methylation in this region and the association with active chromatin marks allow for the continued expression of hTERT.


Subject(s)
Chromatin/genetics , DNA Methylation , Neoplasms/genetics , Telomerase/biosynthesis , Transcription Initiation Site , Alleles , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Caco-2 Cells , Cell Line, Tumor , Chromatin/metabolism , Colonic Neoplasms/genetics , Colonic Neoplasms/metabolism , Gene Expression , HCT116 Cells , Humans , Leukemia/genetics , Leukemia/metabolism , Lung Neoplasms/genetics , Lung Neoplasms/metabolism , Neoplasms/metabolism , Promoter Regions, Genetic , Telomerase/genetics
9.
Arch Environ Contam Toxicol ; 52(2): 179-88, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17165102

ABSTRACT

Organotin compounds (OTs) and representative booster biocides were measured in sediment and mussels from Otsuchi Bay, Japan. The mean amounts of tributyltin (TBT) and triphenyltin (TPT) compounds in sediment were 13 microg kg(-1) dry and 3 microg kg(-1) dry, respectively. Representative booster biocides (Sea-Nine 211, Diuron, Dichlofluanid, Irgarol 1501, M1, which is a degradation compound of Irgarol 1051, and Copper pyrithione) were also detected in sediment from Otsuchi Bay. OT concentrations were higher than those of the measured booster biocides. Otsuchi Bay was divided into four parts by cluster analysis based on OT concentrations in sediment sampled from the bay. These areas included the vicinity of a shipyard, a small fishing port, the closed inner area of the bay, and the mouth of the bay. Higher concentrations of TBT and TPT and a higher ratio of TBT to total BTs were observed in the vicinity of the shipyard. A higher concentration of TPT in comparison with TBT was detected in a small fishing port. Furthermore, OT concentrations in the mouth of the bay were higher than those in the closed-off section. OT concentrations in mussels decreased with distance from the shipyard. Otsuchi Bay was then divided into three parts by cluster analysis based on the concentrations of representative booster biocides found in the bay's sediment. These areas included the vicinity of a shipyard, a small fishing port, and other sites. Concentrations of Diuron and Irgarol 1051 in the vicinity of a shipyard and a small fishing port were dramatically high in comparison with the other sites. Copper pyrithione and Dichlofluanid in addition to Diuron and Irgarol 1051 were also detected in the area of a small fishing port. The concentrations of antifouling biocides were highest in the water in front of the shipyard and showed a marked decrease with distance from the shipyard.


Subject(s)
Bivalvia/chemistry , Disinfectants/analysis , Environmental Monitoring/statistics & numerical data , Environmental Pollutants/analysis , Geologic Sediments/analysis , Organotin Compounds/analysis , Animals , Chromatography, High Pressure Liquid , Cluster Analysis , Gas Chromatography-Mass Spectrometry , Geography , Japan
10.
Mol Cancer Ther ; 5(2): 467-75, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16505122

ABSTRACT

Inhibitors of DNA methyltransferases (DNMT) and histone deacetylases can reactivate epigenetically silenced tumor suppressor genes and thereby decrease tumor cell growth. Little, however, is known on the effects of these compounds in endothelial cell biology and tumor angiogenesis. Here, we show that the DNMT inhibitors 5-aza-2'-deoxycytidine and zebularine markedly decrease vessel formation in different tumor models. We show that DNMT inhibitors are antiproliferative for tumor-conditioned endothelial cells, without affecting endothelial cell apoptosis and migration. Furthermore, these compounds inhibit angiogenesis in vitro and in vivo as shown by inhibition of endothelial cells sprouting in a three-dimensional gel and inhibition of microvessel formation in the chorioallantoic membrane, respectively. 5-Aza-2'-deoxycytidine, as well as the histone deacetylase inhibitor trichostatin A, reactivates the growth-inhibiting genes TSP1, JUNB, and IGFBP3, which are suppressed in tumor-conditioned endothelial cells. Despite enhanced DNMT activity and increased overall genomic methylation levels in tumor-conditioned endothelial cells, silencing of these genes seemed not to be regulated by direct promoter hypermethylation. For IGFBP3, gene expression in endothelial cells correlated with histone H3 acetylation patterns. In conclusion, our data show that DNMT inhibitors have angiostatic activity in addition to their inhibitory effects on tumor cells. This dual action of these compounds makes them promising anticancer therapeutics.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Azacitidine/pharmacology , Cytidine/analogs & derivatives , DNA Modification Methylases/antagonists & inhibitors , Enzyme Inhibitors/pharmacology , Neovascularization, Pathologic/enzymology , Neovascularization, Physiologic/drug effects , Acetylation , Angiogenesis Inhibitors/therapeutic use , Animals , Azacitidine/therapeutic use , Cell Movement/drug effects , Cytidine/pharmacology , Cytidine/therapeutic use , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Enzyme Inhibitors/therapeutic use , Gene Expression/drug effects , Histones/antagonists & inhibitors , Histones/metabolism , Humans , Hydroxamic Acids/pharmacology , Insulin-Like Growth Factor Binding Protein 3/genetics , Melanoma, Experimental/drug therapy , Melanoma, Experimental/enzymology , Melanoma, Experimental/genetics , Mice , Mice, Mutant Strains , Neovascularization, Pathologic/drug therapy , Neovascularization, Pathologic/genetics , Neovascularization, Physiologic/genetics , Thrombospondin 1/genetics
11.
Cancer Res ; 62(24): 7213-8, 2002 Dec 15.
Article in English | MEDLINE | ID: mdl-12499261

ABSTRACT

We examined the relationship between aberrant DNA hypermethylation and key histone code components at a hypermethylated, silenced tumor suppressor gene promoter in human cancer. In lower eukaryotes, methylated H3-lysine 9 (methyl-H3-K9) determines DNA methylation and correlates with repressed gene transcription. Here we show that a zone of deacetylated histone H3 plus methyl-H3-K9 surrounds a hypermethylated, silenced hMLH1 promoter, which, when unmethylated and active, is embedded in methyl-H3-K4 and acetylated H3. Inhibiting DNA methyltransferases, but not histone deacetylases, leads first to promoter demethylation, second to gene reexpression, and finally to complete histone code reversal. Our findings suggest a new paradigm-DNA methylation may directly, or indirectly by inhibiting transcription, maintain key repressive elements of the histone code at a hypermethylated gene promoter in cancer.


Subject(s)
Azacitidine/analogs & derivatives , Gene Silencing/physiology , Histones/genetics , Acetylation , Adaptor Proteins, Signal Transducing , Azacitidine/pharmacology , Carrier Proteins , Colorectal Neoplasms/genetics , Colorectal Neoplasms/metabolism , DNA Methylation/drug effects , DNA Modification Methylases/antagonists & inhibitors , DNA Modification Methylases/metabolism , Decitabine , Gene Expression Regulation, Neoplastic/drug effects , Gene Expression Regulation, Neoplastic/genetics , Histone Deacetylase Inhibitors , Histone Deacetylases/metabolism , Histones/metabolism , Humans , Hydroxamic Acids/pharmacology , Methylation , MutL Protein Homolog 1 , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/genetics , Nuclear Proteins , Promoter Regions, Genetic , Transcription, Genetic/drug effects , Transcription, Genetic/genetics , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...